摘要
阿尔茨海默病(AD)的神经心理学相关冷漠可帮助发现神经生物学的这种行为异常。鉴于先前研究显示AD冷漠与执行功能有关联,遗忘型轻度认知损伤(aMCI) 队列表明与记忆测试有关。采用简单执行测试,也就是执行访问(EXIT-25)和额叶功能评定量表(FAB),我们旨在用低教育、从未接触到胆碱酯酶抑制剂、aMCI (n=26)和轻度AD (n=28)病人的样本进一步研究这个问题。Pietà研究,病人和对照组(n=33)包括来自对巴西老年人(75+ years)脑衰老的成功的社区调查。递交了参与者综合的神经心理学评估和通过情感冷漠量表(AS)的冷漠评估。通过痴呆残疾评估检测,我们发现AD组的AS得分与功能特性有很强的相关性(rho =-0.7 ; p<0,001)。任何执行测试性能与冷漠症状没有关联。冷漠症状也与Mattis痴呆评定量表的记忆力测验和注意力评分性能相关。这些发现加强了甚至在最轻度阶段的AD认知损害范围中的冷漠功能效应,及前期假设的关于冷漠与传统执行功能之间关联的挑战。
关键词: 阿尔茨海默病,冷漠,执行能力,功能性,记忆,轻度认知功能障碍
Current Alzheimer Research
Title:Apathy Is not Associated with Performance in Brief Executive Tests in Patients with Mild Cognitive Impairment and Mild Alzheimers Disease
Volume: 11 Issue: 8
Author(s): Henrique Cerqueira Guimaraes, Patricia Paes Fialho, Viviane Amaral Carvalho, Thais Helena Machado, Etelvina Lucas Santos and Paulo Caramelli
Affiliation:
关键词: 阿尔茨海默病,冷漠,执行能力,功能性,记忆,轻度认知功能障碍
摘要: Neuropsychological correlates of apathy in Alzheimer’s disease (AD) may shed some light on the neurobiology of this behavioral disorder. Whereas previous research has suggested an association between apathy and executive functions in AD, amnestic mild cognitive impairment (aMCI) cohorts point to an association with memory tests. We aimed to further investigate this issue in a sample of low educated, hitherto unexposed to cholinesterase inhibitors, aMCI (n=26) and mild AD (n=28) patients using brief executive tests, namely the Executive Interview (EXIT-25) and the Frontal Assessment Battery (FAB). Patients and controls (n=33) were included from a community-based survey of successful brain aging in Brazilian elderly (75+ years), The Pietà Study. The participants were submitted to a comprehensively neuropsychological assessment and apathy evaluation through the Apathy Scale (AS).We found a strong correlation in AD group between AS scores and functional performance measured by the Disability Assessment in Dementia (rho =-0.7 ; p<0,001). No association was found between any executive test performance and apathy symptoms. Apathy symptoms were also associated with the performance in memory tests and in the attention subscale of the Mattis Dementia Rating Scale. These findings reinforce the functional effect of apathy even in the mildest stages along the AD cognitive impairment spectrum, and challenges previous assumptions regarding the association between apathy and classical executive functions.
Export Options
About this article
Cite this article as:
Henrique Cerqueira Guimaraes, Patricia Paes Fialho, Viviane Amaral Carvalho , Thais Helena Machado, Etelvina Lucas Santos and Caramelli Paulo, Apathy Is not Associated with Performance in Brief Executive Tests in Patients with Mild Cognitive Impairment and Mild Alzheimers Disease, Current Alzheimer Research 2014; 11 (8) . https://dx.doi.org/10.2174/156720501108140910122509
DOI https://dx.doi.org/10.2174/156720501108140910122509 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Responders to ChEI Treatment of Alzheimers Disease Show Restitution of Normal Regional Cortical Activation
Current Alzheimer Research Cognition and Neuropathology in Aging: Multidimensional Perspectives from the Rush Religious Orders Study and Rush Memory and Aging Project
Current Alzheimer Research Metformin: Repurposing Opportunities for Cognitive and Mood Dysfunction
CNS & Neurological Disorders - Drug Targets Biochemical, Biomedical and Metabolic Aspects of Imidazole-Containing Dipeptides with the Inherent Complexity to Neurodegenerative Diseases and Various States of Mental Well-Being: A Challenging Correction and Neurotherapeutic Pharmaceutical Biotechnology for Treating Cognitive Deficits, Depression and Intellectual Disabilities
Current Pharmaceutical Biotechnology Is Alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?
Current Alzheimer Research Editorial (Hot Topic: Neuroprotection and Neuroregeneration in Ischemic Stroke: Emerging Treatment Strategies and Potential Molecular Targets)
Current Drug Targets Vitexin with its Derivatives is Responsible for the Cholinomimetic Properties of <i>Penianthus longifolius</i> Extract which Stimulates Muscarinic Receptors
The Natural Products Journal Subduing the Green-eyed Monster: Bridging the Psychopharmacological and Psychosocial Treatment Perspective in Understanding Pathological Jealousy
Current Drug Targets Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview
Current Pharmaceutical Design Effects of Vitamin A Deficiency and Opioids on Parvalbumin + Interneurons in the Hippocampus of the HIV-1 Transgenic Rat
Current HIV Research Chelating Agents for Metal Intoxication
Current Medicinal Chemistry The Peripheral Nervous System and the Pathogenesis of Prion Diseases
Current Molecular Medicine The Vascular Component of Alzheimer`s Disease
Current Neurovascular Research Properties and Pathogenicity of Prion-Derived Peptides
Protein & Peptide Letters Targeting Heme Oxygenase-1 for Neuroprotection and Neuroinflammation in Neurodegenerative Diseases
Current Drug Targets Auditory Event-related Potentials in Mild Cognitive Impairment and Alzheimer’s Disease
Current Alzheimer Research Annexins as Neuroprotective Agents in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents Testosterone Replacement Therapy in Older Male Subjective Memory Complainers: Double-Blind Randomized Crossover Placebo-Controlled Clinical Trial of Physiological Assessment and Safety
CNS & Neurological Disorders - Drug Targets Sweet and Sour - Oxidative and Carbonyl Stress in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Maternal Vitamin D Status and Development of Asthma and Allergy in Early Childhood
Mini-Reviews in Medicinal Chemistry